Profiel
Scott Filosi is currently the Chief Executive Officer at Diaccurate SA since 2023.
He also holds a current position as the Head-Global Market Access & Pricing at Merck KGaA.
Previously, he worked at Merck KGaA as the Head-Global Market Access & Pricing.
Actieve functies van Scott Filosi
| Bedrijven | Functie | Begin |
|---|---|---|
Diaccurate SA
 Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France. | Algemeen Directeur | 06-11-2023 |
Eerdere bekende functies van Scott Filosi
| Bedrijven | Functie | Einde |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | 01-05-2019 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MERCK KGAA | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Diaccurate SA
Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France. | Health Technology |
